The new corporate headquarters, located in Columbia, South Carolina, serves as the primary distribution center and provides more than threefold the office space and warehousing capabilities of the company’s previous facility.
This new space will accommodate the continued expansion of personnel, which grew by 20% over the last 12 months, and product line offerings, the company said.
Eddie Stiefel, Jr, co-president of BDI Pharma, said: “The transition to a new corporate headquarters and our new name reflects the substantial, but closely and conservatively managed, growth of our organization. We will now serve our customers with even greater resources and enhanced services capabilities.”